Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

CUSIP: 87990A106

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
+2,623,809
Put/Call ratio
36%
SEC-reported price per share
$5.87
Number of holders
79
Value change
+$15,890,634
Number of buys
56
Open additional details 1 more signal available
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
222,722,404

Security key

87990A106

Report period

Q2 2023

Institutions

79

Top holders

10

Ownership snapshot

Top reported holders of TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Casdin Partners Master Fu...
Disclosed value leader
Column Group LLC
Comparable rows
0/15
Latest evidence
31 Mar 2023
3/4/5 13F Highest disclosed value: $26,790,827 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Column Group LLC has the largest disclosed position value at $26.79M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Column Group LLC's linked filing trail.
Disclosed position value Top 5
Casdin Partners Master Fund, L.P. $1.54M
Column Group LLC $26.79M
Eli Casdin $25.9M
Casdin Capital, LLC $17.32M
RA CAPITAL MANAGEMENT, L.P. $17.29M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Casdin Partners Master Fund, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$1,541,988
361,969 shares
— 03 Aug 2021
Column Group LLC
13F
Company
13F
—
denominator unverified
$26,790,827
9,400,290 shares
— 31 Mar 2023
Eli Casdin
3/4/5
Director
—
mixed-class rows
$25,895,944
7,472,698 shares
mixed-class rows
— 17 Nov 2022
Casdin Capital, LLC
13F
Company
13F
—
denominator unverified
$17,324,751
6,078,860 shares
— 31 Mar 2023
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$17,292,327
6,067,483 shares
— 31 Mar 2023
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$12,503,000
4,386,783 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
79
Shares
47,651,950
Rows available
79
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
65
Q2 2023 holders
79
Holder diff
14
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .